Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: GLIOBLASTOMA - DRUG THERAPY , . Treffer: 5
2015
Hoffermann, M; Bruckmann, L; Kariem Mahdy, A; Asslaber, M; Payer, F; von Campe, G
Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.
Clin Neurol Neurosurg. 2015; 128(2):60-69
Doi: 10.1016/j.clineuro.2014.11.006
Web of Science
PubMed
FullText
FullText_MUG
Zhao, Q; Kretschmer, N; Bauer, R; Efferth, T
Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.
Int J Cancer. 2015; 137(6):1446-1456
Doi: 10.1002/ijc.29483
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Hutterer, M; Nowosielski, M; Haybaeck, J; Embacher, S; Stockhammer, F; Gotwald, T; Holzner, B; Capper, D; Preusser, M; Marosi, C; Oberndorfer, S; Moik, M; Buchroithner, J; Seiz, M; Tuettenberg, J; Herrlinger, U; Wick, A; Vajkoczy, P; Stockhammer, G
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).
Neuro Oncol. 2014; 16(1):92-102
Doi: 10.1093/neuonc/not161
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Batchelor, TT; Mulholland, P; Neyns, B; Nabors, LB; Campone, M; Wick, A; Mason, W; Mikkelsen, T; Phuphanich, S; Ashby, LS; Degroot, J; Gattamaneni, R; Cher, L; Rosenthal, M; Payer, F; Jürgensmeier, JM; Jain, RK; Sorensen, AG; Xu, J; Liu, Q; van den Bent, M
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.
J Clin Oncol. 2013; 31(26):3212-3218
Doi: 10.1200/JCO.2012.47.2464
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2012
Stupp, R; Wong, ET; Kanner, AA; Steinberg, D; Engelhard, H; Heidecke, V; Kirson, ED; Taillibert, S; Liebermann, F; Dbaly, V; Ram, Z; Villano, JL; Rainov, N; Weinberg, U; Schiff, D; Kunschner, L; Raizer, J; Honnorat, J; Sloan, A; Malkin, M; Landolfi, JC; Payer, F; Mehdorn, M; Weil, RJ; Pannullo, SC; Westphal, M; Smrcka, M; Chin, L; Kostron, H; Hofer, S; Bruce, J; Cosgrove, R; Paleologous, N; Palti, Y; Gutin, PH
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Eur J Cancer. 2012; 48(14):2192-2202
Doi: 10.1016/j.ejca.2012.04.011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG